Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.
G. Pfeiler
Honoraria - AstraZeneca; Novartis
R. Königsberg
No relevant relationships to disclose
B. Mlineritsch
No relevant relationships to disclose
H. Stoger
No relevant relationships to disclose
C. F. Singer
Honoraria - AstraZeneca; Novartis
S. Poestlberger
Honoraria - AstraZeneca; Novartis; Roche
G. G. Steger
Honoraria - AstraZeneca; Novartis
M. Seifert
Honoraria - AstraZeneca; Novartis
P. C. Dubsky
Honoraria - AstraZeneca; Novartis
R. Jakesz
Consultant or Advisory Role - AstraZeneca; Roche; Sanofi
Honoraria - AstraZeneca; Roche; Sanofi
H. Samonigg
Honoraria - AstraZeneca; Merck; Roche
V. Bjelic-Radisic
No relevant relationships to disclose
R. Greil
Consultant or Advisory Role - AstraZeneca; Novartis
Honoraria - AstraZeneca; Novartis
C. Marth
No relevant relationships to disclose
C. Fesl
No relevant relationships to disclose
M. Gnant
Consultant or Advisory Role - AstraZeneca; Novartis; Pfizer
Honoraria - AstraZeneca; Novartis; Pfizer; Roche; Schering-Plough